SEC Form 4 · accession 0001209191-18-042241

MARVELL TECHNOLOGY GROUP LTD · MRVL

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Director

Period of report

Jul 6, 2018

Accepted (ET)

Jul 10, 2018 · 7:30 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001058057

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common shares^F1	Jul 6, 2018	A	2,143,416	—	A	2,143,416	D
Common shares^F2	Jul 6, 2018	A	558,855	—	A	2,702,271	D
Common shares^F3	Jul 6, 2018	A	1,744,002	—	A	4,446,273	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Restricted stock units^F4,F5	—	Jul 6, 2018	A	9,975	A	—	—	Common shares	9,975	9,975	D
Stock Options (right to buy)^F6	$8.86	Jul 6, 2018	A	504,242	A	Jul 6, 2018	Feb 24, 2019	Common shares	504,242	504,242	D
Stock option (right to buy)^F6	$9.33	Jul 6, 2018	A	403,394	A	Jul 6, 2018	Mar 22, 2020	Common shares	403,394	403,394	D
Stock option (right to buy)^F6	$9.38	Jul 6, 2018	A	322,715	A	Jul 6, 2018	Feb 7, 2021	Common shares	322,715	322,715	D
Stock option (right to buy)^F6	$15.58	Jul 6, 2018	A	130,966	A	Jul 6, 2018	Feb 16, 2022	Common shares	130,966	130,966	D
Stock option (right to buy)^F6	$12.12	Jul 6, 2018	A	224,315	A	Jul 6, 2018	Feb 11, 2023	Common shares	224,315	224,315	D
Stock options (right to buy)^F6	$16.31	Jul 6, 2018	A	178,941	A	Jul 6, 2018	Feb 10, 2027	Common shares	178,941	178,941	D

F1Received in exchange for 985,162 shares of Cavium, Inc. common stock in connection with the merger (the "Merger") of Cavium, Inc. into Marvell Technology Group Ltd. ("Marvell"). On the effective date of the Merger, the Reporting Person received the reported common shares of Marvell.
F2Received in exchange for 265,876 shares of Cavium, Inc. common stock in connection with the merger (the "Merger") of Cavium, Inc. into Marvell Technology Group Ltd. ("Marvell"). On the effective date of the Merger, the Reporting Person received the reported common shares of Marvell.
F3Received in exchange for 801,582 shares of Cavium, Inc. common stock in connection with the merger (the "Merger") of Cavium, Inc. into Marvell Technology Group Ltd. ("Marvell"). On the effective date of the Merger, the Reporting Person received the reported common shares of Marvell.
F4Each restricted stock unit ("RSU") represents a contingent right to receive one Marvell common share.
F5Vests 100% of shares on the earlier of the next annual general meeting of Marvell or June 28, 2019, the one year anniversary of the restricted stock unit grant.
F6Received in the Merger in exchange for employee stock options to acquire shares of Cavium, Inc. common stock.